Article

Kobat, Hasan, Davidson, Michael, Elkonaissi, Islam, Foreman, Emma and Nabhani-Gebara, Shereen (2023) Multiple cardiotoxicities during osimertinib therapy. Journal of Oncology Pharmacy Practice, ISSN (print) 1078-1552 (Epub Ahead of Print)

Kobat, Hasan, Elkonaissi, Islam, Foreman, Emma, O’Brien, Mary, Dorak, Mehmet Tevfik and Nabhani-Gebara, Shereen (2022) Investigating the efficacy of osimertinib and crizotinib in phase 3 clinical trials on anti-cancer treatment-induced cardiotoxicity : are real-world studies the way forward? Journal of Oncology Pharmacy Practice, ISSN (print) 1078-1552 (Epub Ahead of Print)

Kobat, Hasan, Elkonaissi, Islam, Dorak, Mehmet Tevfik and Nabhani-Gebara, Shereen (2021) Management of COVID-19 in cancer patients receiving cardiotoxic anti-cancer therapy. Future recommendations for cardio-oncology. Oncology Reviews, 15(1), ISSN (print) 1970-5557

Conference or Workshop Item

Kobat, Hasan, Booth, Carl and Nabhani-Gebara, Shereen (2022) Understanding cardio-oncology and potential impacts on patients. In: Oncology Professional Care; 24 - 25 May 2022, London, U.K.. (Unpublished)

Kobat, Hasan (2021) International investigation of cardio-oncology practice. In: BOPA 24th Annual Symposium; 08 - 10 Oct 2021, Held online. (Unpublished)

Kobat, H., Elkonaissi, I., Foreman, E., O'Brien, M. and Nabhani-Gebara, S. (2021) Osimertinib and crizotinib cardiotoxicity : are real-world studies the way forward? In: ESMO Congress 2021; 16 - 21 Sep 2021, Paris, France (held online). (Unpublished)